HomeMRTX • NASDAQ
Mirati Therapeutics Inc
$68.18
After Hours:
$68.18
(0.00%)0.00
Closed: Sep 23, 4:00:06 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$69.94
Day range
$66.58 - $70.15
Year range
$32.96 - $195.99
Market cap
3.79B USD
Avg Volume
836.54K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Jun 2022Y/Y change
Revenue
5.36M
Operating expense
182.57M11.20%
Net income
-176.44M-6.02%
Net profit margin
-3.29K
Earnings per share
-3.181.55%
EBITDA
-176.51M-7.78%
Effective tax rate
Total assets
Total liabilities
(USD)Jun 2022Y/Y change
Cash and short-term investments
1.19B-0.89%
Total assets
1.28B-5.60%
Total liabilities
167.79M-26.01%
Total equity
1.11B
Shares outstanding
55.61M
Price to book
3.50
Return on assets
-32.80%
Return on capital
-36.06%
Net change in cash
(USD)Jun 2022Y/Y change
Net income
-176.44M-6.02%
Cash from operations
-143.49M-53.69%
Cash from investing
103.01M180.20%
Cash from financing
1.39M-82.21%
Net change in cash
-39.09M19.86%
Free cash flow
-80.62M-103.29%
About
Mirati Therapeutics is an American targeted oncology company that focuses on the development of cancer therapeutics. Wikipedia
Founded
1995
Website
Employees
413
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for